Trauma Biologist: A Profile of Israel Liberzon

The University of Michigan neuroscientist has developed therapies for patients with PTSD and laboratory models to understand its basis.

Written byAnna Azvolinsky
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

Israel Liberzon
Theophile Raphael Professor of Neuroscience; Professor
of Psychiatry and Psychology; Co-director,
Center for Trauma, Stress, and Anxiety,
University of Michigan
Professor of Psychology, University of Michigan
Diplomat of the American Board of Psychiatry
and Neurology
Past President, Psychiatric Research Society (2003)
COURTESY OF ISRAEL LIBERZON
Israel Liberzon discovered his natural proclivity for post-traumatic stress disorder (PTSD) research when he arrived at the University of Michigan (UM) and Veterans Administration Ann Arbor Medical Center in the 1980s. There, he encountered numerous combat veterans with the condition. “The veterans tended not to like the doctors, who they thought couldn’t relate to them. It was always very natural and easy for me to relate to my veteran patients, to understand where they were coming from,” says Liberzon. “I didn’t have the barriers of communication that other clinicians had because I had the combat experience in common with the patients.”

Liberzon had served a mandatory three years in the Israeli Defense Forces starting at age 18. There, he trained as a combat paramedic and became part of an airborne unit, treating soldiers and civilians wounded in combat zones.

He says he feels fortunate to have made personal connections with such patients. Most that he treated in the UM VA system were Vietnam War veterans, but there were also older vets who’d served in World War II and the Korean War. “It was fascinating because they were experiencing things and dealing with things that were forty years old, and they still had a profound effect on their daily life,” Liberzon says. One of his most memorable patients had been a WWII pilot, who, on the way ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • head shot of blond woman wearing glasses

    Anna Azvolinsky received a PhD in molecular biology in November 2008 from Princeton University. Her graduate research focused on a genome-wide analyses of genomic integrity and DNA replication. She did a one-year post-doctoral fellowship at Memorial Sloan Kettering Cancer Center in New York City and then left academia to pursue science writing. She has been a freelance science writer since 2012, based in New York City.

    View Full Profile

Published In

June 2018

Microbial Treasure

Newly discovered archaea reveal bizarre biology

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies